Despite slowdowns in research suffered by universities around the world due to the pandemic, the University of Arizona has experienced solid growth in the commercialization of university inventions.

A University of Arizona study on Type 2 diabetes could completely alter the way the disease is treated by fighting it a different way.

Working to prevent Type 2 diabetes, researchers at the University of Arizona are collaborating with scientists universities around the nation to study the connection between fatty liver, the brain, and metabolic disease.

Innovative minds spanning several disciplines created partnerships to advance research and impact the lives of Arizonans at the second annual BIO5/BIOSA Faculty Industry Networking Event.

The founders of GenetiRate, including BIO5’s Dr. Benjamin Renquist shared in a $25,000 grand prize sponsored by UAVenture Capital after the “Shark Tank”-style pitch competition that took place during the 2019 TenWest Impact Festival.

GenetiRate has developed a method to predict feed conversion in rainbow trout, based off of metabolic rates.

The Arizona Biomedical Research Commission has recognized 14 researchers from the UA Health Sciences to receive grant awards totaling more than $5.92 million. Eight of those researchers are BIO5 members.